Nevada medicaid and nevada check up pharmacy manual version 2 may 15, 2012.
Nevada check up manual transmittal letter december 11, 2014 to: custodians of nevada check up manual from: tammy moffitt, chief, program of integrity.
Brian Sandoval Governor Laurie Squartsoff Administrator Division of Health Care Financing and Policy Medicaid and Nevada Check Up Overview January 2015.
- Medicaid Services Manual and Nevada Check Up Manual Updated Changes to the Medicaid Services Manual (MSM) Chapter 400 (Mental Health and Alcohol/Substance.
- NV Medicaid Billing Manual. By admin. BILLING MANUAL FOR NEVADA MEDICAID AND. NEVADA CHECK UP. Nevada Medicaid Management Information System.
- Nevada MMIS 270 Companion Guide Billing Manual for Nevada Medicaid and Nevada Check Up NEVADA MEDICAID AND NEVADA CHECK UP Updated April 21, 2014 Change history Date.
- Division of Nevada Welfare and Supportive Services is to provide quality, timely and temporary services enabling Nevada families, the disabled and elderly to achieve.
NEVADA MEDICAID AND NEVADA CHECK UP PHARMACY MANUAL VERSION 2 May 15, 2012 Copyright© 2012 by SXC Health Solutions, Inc. All rights reserved. This document is intended to be a helpful resource to SXC Health Solutions Pharmacies providing services to Nevada Medicaid and Nevada Check Up Recipients. A copy of this document is posted on the SXC website for ease of reference. The manual is updated regularly with program changes. The version number and date of update is shown on cover page of the manual. The most current version of the manual can be found by following the links on the HPES/SXC Nevada Medicaid and Nevada Check Up website https://www.medicaid.nv.gov; select “Billing Information” from the “Pharmacy” tab. Updated 05/15/2012 (previous version 12/05/2011) Updated 05/15/2012 Page 2 of 27 TABLE OF CONTENTS Table of Contents .......................................................................................................................................................................... 3 1.0 1.1 1.2 1.3 1.4 2.0 2.1 2.2 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 Introduction ...................................................................................................................................................................... 5 Nevada Medicaid Provider Telephone Numbers .................................................................................................................... 5 State Policy ............................................................................................................................................................................... 5 HPES/SXC Website ................................................................................................................................................................... 6 System Availability .................................................................................................................................................................. 6 Program Setup .................................................................................................................................................................. 6 Claim Submission ..................................................................................................................................................................... 6 Timely Filing Limits .................................................................................................................................................................. 7 Program Requirements ..................................................................................................................................................... 7 Dispensing Limits ..................................................................................................................................................................... 7 Tamper Resistant Prescriptions ............................................................................................................................................... 9 E‐ Prescribing ......................................................................................................................................................................... 10 Generic Substitution Policy ................................................................................................................................................... 10 Maximum Allowable Cost (MAC) List .................................................................................................................................... 10 Covered and Non‐Covered Drugs .......................................................................................................................................... 11 Covered OTC Drugs ................................................................................................................................................................ 11 Recipient Co‐Pay Information ............................................................................................................................................... 12 Prior Authorization Procedures and Diagnosis Codes .......................................................................................................... 12 The Preferred Drug List .......................................................................................................................................................... 13 Emergency Supply Policy ....................................................................................................................................................... 13 Updated 05/15/2012 Page 3 of 27 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 4.0 4.1 4.2 4.3 5.0 5.1 5.2 5.3 5.4 6.0 Coordination of Benefits ....................................................................................................................................................... 14 Medicare Part D Plan (PDP) and Dual‐eligible Recipients .................................................................................................... 16 Family Planning drugs ............................................................................................................................................................ 17 Hospice Drugs ........................................................................................................................................................................ 17 Long‐Term Care Claims .......................................................................................................................................................... 18 Special Recipient Conditions (“Locked‐in” Patients) ............................................................................................................ 19 Compounds ............................................................................................................................................................................ 19 Partial Fill Functionality ......................................................................................................................................................... 21 Injectable Drugs ..................................................................................................................................................................... 22 Refills ...................................................................................................................................................................................... 22 Vacation Fill ............................................................................................................................................................................ 22 Lost Medication ..................................................................................................................................................................... 22 Prospective Drug Utilization Review (ProDUR) ................................................................................................................. 22 Therapeutic and Clinical Edits ............................................................................................................................................... 24 Call Centers ............................................................................................................................................................................ 24 ProDUR Alert/Error Messages ............................................................................................................................................... 24 Provider Reimbursement ................................................................................................................................................ 25 Switching Fees........................................................................................................................................................................ 25 Ambulatory/LTC Network Pharmacy Payment Algorithms .................................................................................................. 25 Ambulatory/LTC Network Pharmacy Dispensing Fees ......................................................................................................... 26 Pharmacist‐Administered Immunizations ............................................................................................................................ 26 Provider Education .......................................................................................................................................................... 27 Updated 05/15/2012 Page 4 of 27 1.0 INTRODUCTION Effective January 1, 2012, the Point‐of‐Sale (POS) system will require pharmacies to submit claims to SXC Health Solutions electronically in the National Council for Prescription Drug Programs (NCPDP) standardized Version 5.1 or Version D.0; lower versions will not be accepted. Beginning April 1, 2012, NCPDP Version D.0 will be the only version accepted. After submission, SXC will respond to the pharmacy provider with information regarding recipient eligibility, Nevada Medicaid allowed amount, applicable Prospective Drug Utilization Review (ProDUR) messages, and applicable Rejection messages. ProDUR messages will be returned in the DUR response fields; other important related information will be displayed in the free form message area. It is extremely important that pharmacies display all messages exactly as returned by SXC. All arrangements with switching companies should be handled directly by the pharmacy with their preferred switching company. Pharmacies must submit claims within 90 days of the date of service. 1.1 NEVADA MEDICAID PROVIDER TELEPHONE NUMBERS Responsibility SXC Technical Call Center (Pharmacy Help Desk) SXC Clinical Call Center (Prior Authorizations) Phone Numbers 866‐244‐8554 855‐455‐3311 855‐455‐3303(fax) 24/7/365 24/7/365 Availability 1.2 STATE POLICY Nevada Medicaid State policy is in Chapter 1200 of the Medicaid Services Manual (MSM). The MSM is on the Division of Health Care Financing and Policy (DHCFP) website at https://dhcfp.nv.gov Updated 05/15/2012 Page 5 of 27 1.3 HPES/SXC WEBSITE Announcements, meeting dates and policy updates are posted to the HPES/SXC website as they become available. It is recommended that users visit https://www.medicaid.nv.gov weekly to view the latest information. Pharmacy information is under the “Pharmacy” menu. 1.4 SYSTEM AVAILABILITY The POS system is available 24 hours per day 7 days a week 365 days per year except during scheduled routine maintenance. In the rare instance the POS system is down for any reason, hold your claims until online capability resumes. 2.0 PROGRAM SETUP 2.1 CLAIM SUBMISSION · · · · NCPDP version 5.1 format is accepted for all POS submissions through March 31, 2012. NCPDP version D.0 format is accepted for all POS submissions beginning January 1, 2012. NCPDP version D.0 format will be the only accepted format for all POS submissions beginning April 1, 2012. No other POS claim submission formats will be accepted. The following list provides important identification numbers for this program: ANSI BIN # Processor Control # Provider ID # Cardholder ID # Prescriber ID # Product Code · · A group number is not needed for a NV Medicaid transaction. The Nevada Medicaid Pharmacy card will list the recipient’s ID number, name and date of birth. 001553 NVM National Provider Identifier NV Medicaid Pharmacy ID Number or SSN National Provider Identifier National Drug Code (NDC) Updated 05/15/2012 Page 6 of 27 · · This recipient information must be entered exactly as it appears on the card (including any hyphens, apostrophes, etc.). A middle initial is not mandated. 2.2 TIMELY FILING LIMITS Most pharmacies submit point‐of‐sale‐claims at the time of dispensing; however there may be extenuating circumstances that require a claim to be submitted after being dispensed. · · · For all original claims and adjustments, the timely filing limit from the date of service (DOS) is 180 days. For all original claims and adjustments involving other third party payers, the timely filing limit from the date of service (DOS) is 365 days. Claims for persons who are retroactively determined eligible for Medicaid must be received no later than 180 days after the date of eligibility determination or the date of service, whichever is later. · · Claims that exceed the prescribed timely filing limit are denied. o (NCPDP EC #81/Timely Filing Exceeded). Providers should contact the SXC Technical Call Center at 1‐866‐244‐8554 for late claim override consideration. 3.0 PROGRAM REQUIREMENTS 3.1 DISPENSING LIMITS Days’ Supply · There is a per claim day supply maximum of 34 days*. Updated 05/15/2012 Page 7 of 27 *Drug Agents which allow up to 100 days’ supply Contraceptives, Topical Anticonvulsants Estrogens Contraceptives, Oral Antihypertensives Antianginals · If 80% of a non‐controlled or 90% of a controlled medication has been utilized (the system will calculate back to the original fill date) the system will automatically allow the claim to go through. If 80% of a non‐controlled or 90% of a controlled medication has not been used, the system will message back the next date the prescription may be filled. Antiarrhythmics Thyroid Preparations Progesterone Antidiabetics Cardiac Glycosides Diuretics Dose/Duration · All claims are interrogated against the Preferred Drug List (PDL), benefit requirements and DUR criteria. A complete listing of prior authorization criteria, step therapy requirements, quantity limits, and duration of therapy edits can be found online through the DHCFP’s website (https://dhcfp.nv.gov). All claims are interrogated for compliance with state and federal requirements. Prescriptions must be dispensed pursuant to the orders of a physician or legally authorized prescriber. Any subsequent refills may be dispensed not more than one year from the date the prescription was written (or earlier whenever legally dictated). CIIs may not be refilled; a new prescription is required for each fill. Controlled drugs other than CIIs may be refilled, pursuant to the order of a physician or legally authorized prescriber, up to five refills or six months, whichever comes first. Non‐controlled drugs may be refilled, pursuant to the order of a physician or legally authorized prescriber, up to one year. · · · · · Updated 05/15/2012 Page 8 of 27 3.2 TAMPER RESISTANT PRESCRIPTIONS Medicaid is mandated by Federal statute to require all written (non‐electronic) prescriptions for all outpatient drugs for Medicaid recipients to be on tamper‐resistant prescription pads. This requirement does not apply to e‐prescriptions transmitted to the pharmacy, prescriptions faxed to the pharmacy or prescriptions communicated to the pharmacy by telephone by a prescriber. As of October 1, 2008, prescriptions are required to have a minimum of one feature from each of the three CMS categories listed below: 1) Industry‐recognized feature(s) designed to prevent unauthorized copying. Feature “Void” or “Illegal” pantograph Description The word “Void” appears when the prescription is photocopied. Due to the word “Void” on faxed prescriptions, this feature requires the pharmacy to document if the prescription was faxed. Special paper containing “watermarking.” Watermarking 2) Industry‐recognized feature(s) designed to prevent erasure or modification written by the prescriber. Feature Quantity check off boxes with Description In addition to the written quantity on the prescription, quantities are indicated in ranges. It is recommended that ranges be 25’s with the highest being “151 and over.” The range box corresponding to the quantity prescribed MUST be checked for the Refill Indicator (circle or prescription to be valid. check number of refills Indicates the number of refills on the prescription. Refill number must be used to be a or “NR”) valid prescription. Document if the prescription was faxed. Uniform non‐white background color Background that consists of a solid color or consistent pattern that has been printed onto the paper. This will inhibit a forger from physically erasing written or printed information on a prescription form. If someone tries to erase or copy, the consistent background color will look altered and show the color 3) Industry‐recognized feature(s) designed to prevent use of counterfeit prescription forms. Feature Security features and descriptions listed on prescriptions Heat sensing imprint Description Complete list of the security features on the prescription paper for compliance purposes. By touching the imprint or design, the imprint will disappear. Be advised that all prescriptions paid for by Nevada Medicaid must follow these State/Federal regulations. Updated 05/15/2012 Page 9 of 27 3.3 E ‐ PRESCRIBING Nevada Medicaid encourages prescribers to submit electronic prescriptions. Recipient pharmacy claims history, eligibility, drug coverage data and the indication of the need for a PA are also available to prescribers who use electronic prescribing systems. Prescribers who use electronic prescribing systems can arrange for appropriate access to this data by contacting their software vendors. For more information, see the HPES website, select E‐prescribing under Provider’s menu. 3.4 GENERIC SUBSTITUTION POLICY Per Nevada Revised Statute (NRS) 639.2583, if the practitioner has not indicated that generic substitution is prohibited, the pharmacy provider must dispense, in substitution, another drug that is available to him if the other drug: · · · · Is less expensive than the drug prescribed by brand name; Is biologically equivalent to the drug prescribed by brand name; Has the same active ingredient or ingredient of the same strength, quantity and form of dosage as the drug prescribed by brand name; and Is of the same generic type as the drug prescribed by brand name and the least expensive of the drugs that are available to him for substitution. Should a prescriber indicate that a branded drug is medically necessary for a recipient, the prescriber must comply with the following: · · · · The physician should document in the recipient’s medical record the need for the brand name product in place of the generic form. The certification must be in the physician’s own handwriting. Certification must be written directly on the prescription blank. The phrase “Dispense as written” is required on the face of the prescription. For electronically transmitted prescriptions “Dispense as written” must be noted. Not acceptable: a printed box on the prescription blank checked by the prescriber to indicate “brand necessary” or a handwritten statement transferred to a rubber stamp and then stamped on the prescription. A prior authorization is required to override generic substitution. Certification is not required if a generic is not manufactured. A fax copy/verbal order may be taken by the pharmacist from the physician, but the pharmacy must obtain an original printed copy and keep on file. · · · 3.5 MAXIMUM ALLOWABLE COST (MAC) LIST · State Maximum Allowable Costs is the upper reimbursement limit for multi‐source outpatient pharmaceuticals established by the DHCFP or Fiscal Agent. Updated 05/15/2012 Page 10 of 27 · The MAC List is updated monthly. Providers may access information regarding the SXC /Nevada Medicaid Maximum Allowable Cost by viewing the following link: http://www.medicaid.nv.gov (from the “Pharmacy” tab select “MAC Information.” Providers who have questions or concerns about a particular MAC price may submit a MAC Price Research Request Form which can be found on the Nevada Website: http://www.medicaid.nv.gov. Providers may appeal the current SMAC for pharmaceutical product if a provider determines that a particular multi‐ source drug is not available at the current SMAC reimbursement. § § § § The pharmacy must contact the Fiscal Agent technical call center to initiate the appeal. Information needed to make the decision will include NDC number, manufacturer, drug name, strength and price paid. A faxed copy of the actual invoice for the drug may be requested. Inquires not resolved by the technical call center are forwarded to the Fiscal Agent’s SMAC Coordinator for investigation and resolution. If it is determined the SMAC is negatively impacting access to care for recipients, the SMAC Coordinator has the authority to 1) adjust SMAC pricing for the particular claim being appealed, and 2) make changes to the SMAC pricing file. Appeals will be responded to within three working days of the referral to the SMAC Coordinator. · · § 3.6 COVERED AND NON ‐ COVERED DRUGS The Nevada Medicaid Drug program will pay for medications as outlined in Medicaid Services Manual, Chapter 1200. § § § § § § § § § § § Covered legend and non‐legend pharmaceutical manufacturers must participate in the federal Medicaid Drug Rebate Program unless listed on the excluded list in Chapter 1200 of the Medicaid Services Manual. Pharmaceuticals must be prescribed for a medically accepted indication. Family planning items such as diaphragms, condoms, foams and jellies are a covered benefit. The Nevada Medicaid Drug Rebate Program will not reimburse for the following pharmaceuticals: Agents used for weight loss Agents used to promote fertility Agents used for cosmetic purposes or hair growth Yohimbine Drug Efficacy Study and Implementation (DESI) list “Less than Effective Drugs” Pharmaceuticals considered “Experimental” as to substance or diagnosis for which prescribed Pharmaceuticals manufactured by companies not participating in the federal Medicaid Drug Rebate Program unless rated “1‐A” by the FDA Agents used for impotence/erectile dysfunction 3.7 COVERED OTC DRUGS · Over‐the‐counter medications are a covered Nevada Medicaid benefit subject to Prior Authorization. Page 11 of 27 Updated 05/15/2012 § Coverage is limited to two prescriptions per month within the same Standard Therapeutic Class (please see Appendix B of Chapter 1200 of the Medicaid Services Manual for a list of Standard Therapeutic Classes) without PA. Any more than two prescription request for medications within the same therapeutic class will require PA. Insulin will be exempt from any Clinical PA requirements. § 3.8 RECIPIENT CO ‐ PAY INFORMATION · Nevada Medicaid and Nevada Check Up do not require the recipient to pay a co‐pay. 3.9 PRIOR AUTHORIZATION PROCEDURES AND DIAGNOSIS CODES Technical Call Center The SXC Technical Call Center‐ (866) 244‐8554 assists in the following circumstances on behalf of Nevada Medicaid. Early Refills (DUR Reject 79): The Technical Call Center may assist in overriding this reject if one of the following circumstances exists: · · · Dosage/Therapy change has occurred; recipient is no longer taking the original dosage. Dosage Time/Frequency Change has occurred. 2 strengths of the same drug are used to make a strength of that medication not currently manufactured. ** At this time, no other exceptions will be made ** Clinical Call Center The SXC Clinical Call Center‐ (855) 455‐3311 assists in the following authorization requests/overrides on behalf of Nevada Medicaid: · · · · Preferred Drug List (PDL) Step Therapy Clinical Criteria Dose Optimization Special Accumulation limits Hydrocodone 1200 mg per rolling 30 days Oxycodone 1200 mg per rolling 30 days Acetaminophen 4 gm per day To request prior authorization for the edits listed above, the prescribing physician or the prescribing physician’s agent must call the SXC Clinical Call Center at (855) 455‐3311. Prescribers may also initiate a prior authorization by faxing the appropriate request form to (855) 455‐3303. Should the pharmacist have access to the applicable clinical information, they may initiate the Prior Authorization request. · · · · Therapeutic Duplication Drug‐Drug Interaction All Other Clinical Edits Quantity Limits Updated 05/15/2012 Page 12 of 27 · SXC provides a Provider Portal for a physician or their agent to enter the required clinical information required for a Prior Authorization decision. This portal gives an instant decision and is strongly suggested as the first level of prior authorization processing. The portal may be accessed through http://www.medicaid.nv.gov. From the “Pharmacy” tab, select “Pharmacy Web PA Login.” Ideally Prior Authorizations should be obtained at the time the prescription is being written. If this does not occur, the claim is denied at POS with a message that the prescriber should contact (855) 455‐3311 for prior authorization consideration. The SXC Clinical Call Center responds to all prior authorization requests within 24 hours of initiation. o If more information is needed from the prescriber to make a determination for the prior authorization, the physician has three business days to respond to any such request. After that, the request will be denied. · · · · It is not necessary to enter a PA number when the claim is transmitted. An active PA record in the SXC system is all that is necessary. Prior authorization edits apply to all claims. Appropriate Diagnosis for Prior Authorization Bypass In an effort to assist Prescribers and Providers, Prior Authorization requirements can be bypassed for certain medications when specific medical conditions exist. Those specific medications and diagnoses are noted in the Nevada Medicaid Services Manual, Chapter 1200. Prescribers are encouraged to include the applicable diagnosis code on written prescriptions for inclusion on the electronic pharmacy claim. The submitted claim should include a Diagnosis Code Qualifier (field 492‐WE) of “01,” indicating ICD‐9, as well as the appropriate Diagnosis Code (field 424‐DO). 3.10 THE PREFERRED DRUG LIST Nevada Medicaid and Nevada Check Up utilizes a Preferred Drug List (PDL). Non‐preferred drugs in the listed classes require Standard PDL Exception Criteria prior authorization. The PDL can be found on the HPES/SXC website https://www.medicaid.nv.gov. Visit this website to ensure you have the most recent version of the PDL as it is updated periodically. 3.11 EMERGENCY SUPPLY POLICY If the prescriber is not available and the pharmacist feels the recipient needs to receive the prescribed drug, the pharmacist should contact the Clinical Call Center at: (855) 455‐3311. SXC may authorize up to a 96‐hour emergency supply. NOTE: An emergency situation is a situation that, in the judgment of the dispensing pharmacist, involves an immediate threat of severe adverse consequences to the recipient, or the continuation of immediate and severe adverse consequences to the recipient, if an outpatient drug is not dispensed when a prescription is submitted. Updated 05/15/2012 Page 13 of 27 3.12 COORDINATION OF BENEFITS It is important that Providers be aware that Nevada Medicaid is always the payer of last resort, except as defined in Medicaid Services Manual Chapter 100. Each Nevada Medicaid recipient should be asked whether he/she is covered by any pharmacy insurance provider other than Medicaid. If the recipient identifies any other pharmacy payer(s), the pharmacy is required to bill all other payers prior to billing pharmacy claims to Nevada Medicaid. · As a matter of program policy, providers must bill all other payers first and then bill Nevada Medicaid. Nevada Medicaid is always the payer of last resort. If the recipient shows other coverage on the date of service (DOS), the pharmacy will receive a “41” Reject Code— Submit to Primary Payer. The pharmacy will also receive a message with information about the recipient’s TPL, including the PCN (if applicable), BIN number, Identification Number, Group Number, and telephone number to the Nevada Medicaid recipient’s primary insurance plan. The pharmacy must then submit the claim to the primary insurance for payment. If other payment is received, providers must resubmit the prescription claim to Nevada Medicaid with the following information for payment consideration (see COB Reference Guide below and Payer Specification Sheet in Section 7.0 for complete detailed situations). r r OTHER COVERAGE CODE (NCPDP #308‐C8) = only values of “2”, “3”, or “4” in this field are accepted. OTHER PAYER AMOUNT PAID field (NCPDP #431‐DV) = amount received from all other payers (must be greater than $0.00). OTHER PAYER DATE (NCPDP #443‐E8) = date payment received from other payer. · · · · r · In all cases, SXC Health Solutions uses the Nevada Medicaid “Allowed Amount” when calculating payment. If the primary insurer has reimbursed greater than the Nevada Medicaid Allowed Amount, this may result in zero payment on the secondary claim. Updated 05/15/2012 Page 14 of 27 Nevada Medicaid Pharmacy Coordination of Benefits Requirements NCPDP #308‐C8 O‐ Not Specified When to Use Allowed; submit when recipient does not have other health insurance. Submit Processed as Primary, reject 41 if TPL on recipient record Submission Requirements / Responses Claim will reject with a 41 error if recipient record has alternate insurance. Additional fields in the NCPDP COB segment should not be submitted with this OCC. Claim should be sent to Primary Insurance and then resubmitted with proper OCC and other required fields. 1‐ No Other Coverage Allowed; This code value indicates that they did attempt to determine if there was other coverage but weren’t able to find any Claim will reject with a 41 error if recipient record has alternate insurance. Additional fields in the NCPDP COB segment should not be submitted with this OCC. Claim should be sent to Primary Insurance and then resubmitted with proper OCC and other required fields or call Customer Care for 41 reject override. Paid claim; also requires submission of: Other Payer Amount Paid (431‐DV) that is > $0 Other Payer Amount Paid Qualifier (342‐HC) that is valid Recipient Paid Amount Submitted (433‐DX) this is => $0 Other Payer Date (443‐E8) that is valid Other Payer ID (340‐7C) that is valid Other Payer ID Qualifier (339‐6C) that is valid Claims submitted without proper required COB fields will reject with code 13. 2‐ Exists Payment Collected OCC 2 is used when any positive amount of money is collected from another payer. Submit the amount collected from the primary payer (TPL), along with the date the claim was adjudicated to the primary payer (TPL) in order override the TPL denial. 3‐ Exists Claim Not Covered OCC 3 is used when the Nevada Medicaid beneficiary has other primary insurance, but the particular drug is not covered by the specific plan(s). Requires submission of: Other Payer Date (443‐E8) Other Payer ID (340‐7C) Other Payer ID Qualifier (339‐6C) And the reject code generated after billing the other insurer(s) in the “Other Payer Reject Code (472‐6E). Claim will pay only if the following Other Payer Reject codes are submitted: 60, 61, 63, 65, 66, 67, 68, 69, 70, 3Y Claims submitted without proper required COB fields will reject with code 13. Updated 05/15/2012 Page 15 of 27 4‐ Exists Payment Not Collected OCC 4 is used when a recipient’s primary insurance plan is active, but there is no payment collected from the primary insurer because the beneficiary has not met their primary payer’s deductible obligation. This value should also be used if the total cost of the claim is less than the recipient’s primary insurance co‐pay requirement and the primary insurance plan made no payment. Paid claim; also requires submission of : Other Payer Amount Paid (431‐DV) that = $0 Other Payer Amount Paid Qualifier (342‐HC) Recipient Paid Amount Submitted (433‐DX) this is > $0 Other Payer Date (443‐E8) that is valid Other Payer ID (340‐7C) that is valid Other Payer ID Qualifier (339‐6C) Claims submitted without proper required COB fields will reject with code 13. 8‐ Claim Billing for a Copay OCC 8 is used when billing a copay from Medicare Part D Paid claim; also requires submission of: Other Payer Amount Paid (431‐DV) that is > $0 Other Payer Amount Paid Qualifier (342‐HC) that is valid Recipient Paid Amount Submitted (433‐DX) this is => $0 Other Payer Date (443‐E8) that is valid Other Payer ID (340‐7C) that is valid Other Payer ID Qualifier (339‐6C) that is valid Claim submitted without proper required COB fields will reject with NCPDP code 13. 3.13 MEDICARE PART D PLAN (PDP) AND DUAL ‐ ELIGIBLE RECIPIENTS Recipients eligible for both Medicare and Medicaid benefits (“dual‐eligibles”) will receive prescription drug coverage through a Medicare Part D Prescription Drug Plan (PDP). All claims for dual‐eligibles must be billed to the recipient’s Medicare PDP prior to billing Medicaid. Submit the claim to Medicaid using standard COB processing, i.e., include all required COB processing fields. Medicare Excluded Drugs Some drugs are not covered by the Medicare PDP. Medicare excluded drug categories are: · · · Updated 05/15/2012 OTC Medications Cough and Cold Medications Vitamin and Mineral Supplements including Prenatal Vitamins Page 16 of 27 · · Barbiturates Benzodiazepines Submit your claim to Medicaid after the Medicare PDP denies the claim as a non‐covered benefit. Enter a “3” (Other coverage exists, this claim not covered) in Field 308‐C8 (Other Coverage Code). Medicaid requires a prescription for all drugs, prescribed and OTC. All current Medicaid limitations and exclusions apply to claims not covered by a recipients’ Medicare PDP Co‐Payment Claims Medicaid will cover prescription co‐payments ($1.10 for generics, $3.30 for brands) for non‐institutionalized dual‐eligibles who have an eligibility code of “A”, “B”, “5” or “S.” Medicaid will not reimburse Part D co‐pays for recipients in LTC facilities as these co‐pays are waived per federal Medicare regulations. Medicaid does not cover co‐pays ($2.40 for generics, $6.00 for brands) for dual‐eligibles with an eligibility code of “5” or “S.” Medicaid co‐pay logic does not allow for the reimbursement of a dual‐eligible co‐pay for an amount greater than $3.30. For Medicare Part B covered drugs, the co‐pay amount can and will exceed this amount in most cases. To exceed the current $3.30 co‐ pay maximum for Part B covered drugs for recipients with Part B and D, bill Medicare Part B as the primary payer. Medicaid can be billed as the secondary payer using standard COB billing practices. For Part B covered drugs, enter the Other Coverage Code of "2" (Field 308‐ C8). The Gross Amount Due (Field 430‐DU) should equal the Medicare allowed amount. Diabetic Supplies Blood glucose testing equipment and supplies, as well as injection devices, are a Part B‐covered benefit. These items are not considered Part D drugs and therefore are not a Part D benefit. After billing Medicare Part B for these items, Medicaid can be billed as the secondary payer using standard COB billing practices. Enter the Other Coverage Code of "2" (Field 308‐ C8). The Gross Amount Due (Field 430‐DU) should equal the Medicare allowed amount. The Part D carrier code, 07450 (Field 340‐7C) and Part B carrier code, 04967, are required for processing diabetic supply claims for recipients that are eligible for Medicaid, Medicare Part D and Medicare Part B. 3.14 FAMILY PLANNING DRUGS You may submit claims for family planning drugs directly to Medicaid without billing a primary insurance carrier first. 3.15 HOSPICE DRUGS As stated in MSM Chapter 3200, drugs, supplies and durable medical equipment prescribed for conditions other than for the palliative care and management of the terminal illness are not covered benefits under the Nevada Medicaid hospice program and are to be billed in accordance with the appropriate Medicaid Services Manual chapter for those services. Updated 05/15/2012 Page 17 of 27 Hospice recipients can be identified by: · · Information on the recipient’s Medicaid enrollment file, or The PATIENT LOCATION code (Field 307‐C7) on the inbound claim contains a code “11” (Hospice). To bill for a drug that is unrelated to the terminal illness, use override code “08” in Field 461‐EU (Payer Defined Exemption). 3.16 · LONG ‐ TERM CARE CLAIMS Drugs that are generally included in the per diem rate are not a covered benefit. Refer to Medicaid Services Manual Chapter 500 for complete information on LTC. Non‐billable Items o IV Hydration therapy of standard fluids without additives (e.g. antibiotics, potassium and heparin) and supplies associated with I.V. therapy, enteral nutrition and TPN administration are part of the LTC or Nursing Facility per diem rate and may not be billed as a separate charge. The following items are not billable for recipients in an LTC facility (they are considered covered through the per diem rate). § § § § § § § § § § Dental supplies Disposable supplies Emollient supplies Endocrine supplies Fluid and electrolyte supplies Metabolic, nutritional and temperature supplies Respiratory supplies Supplements (see MSM Chapter 1300) Urological Supplies Wound Care Supplies · · · Billable Items o I.V. Drugs/TPN may be billed as a separate charge for recipients in LTC facilities. Unit Dose Repackaging Incentive o o An incentive plan is available to pharmacies who repackage non‐unit dose products (tablets and capsules) to recipients in a LTC facility. Email [email protected] for enrollment and program details. Enrolled pharmacies are entitled to a per claim incentive fee of $0.43. Submit this fee in the INCENTIVE AMOUNT SUBMITTED field (438‐E3). Additionally, submit a value of “3” (Pharmacy Unit Dose) in the UNIT DOSE INDICATOR field (Field 429‐DT). In addition, nursing facilities must properly credit the Medicaid program for the return of unused prescription medicines upon discontinuance of the prescription or transfer, discharge or death of a Medicaid beneficiary. This is to assure there is no double billing of medications. o Updated 05/15/2012 Page 18 of 27 · Drugs Indicated as Unit Dose: As indicated by Medispan, most unit dose drugs are covered for recipients in LTC facilities only. If a medication is ONLY available as in unit dose packaging, coverage will also be included for non‐ LTC recipients. Please note: Recipients who reside in “Assisted Living Facilities” are not considered as “Long‐Term Care” recipients. · Identify claims for recipients in a LTC facility by entering “04” (Long Term/Extended Care) in Field 307‐C7 (Patient Location). 3.17 · · SPECIAL RECIPIENT CONDITIONS (“LOCKED ‐ IN” PATIENTS) When a recipient shows patterns of abuse/misuse of benefits, the recipient can be “Locked In” to a pharmacy. Recipients may be locked into a designated pharmacy. Pharmacies will receive a NCPDP‐50 reject if they try to fill a prescription from an unauthorized pharmacy. In the event of an emergency, SXC may be contacted for override consideration. Any Nevada Medicaid participating pharmacy has the right to accept or decline any “locked‐in” Nevada Medicaid recipient only after contacting the SXC Technical Help Desk at 1‐866‐244‐8554. · 3.18 COMPOUNDS A $4.76 dispensing fee applies to all compound claims except home I.V. antibiotics. Compound Claims Processing · All compounds must be submitted using the NCPDP version D.0 standard multi‐ingredient compound functionality. Therefore, all ingredients must be identified, their units must be indicated, and the ingredient cost for each ingredient must be submitted on the claim. At least one item in the compound must be a covered drug. If an excluded or non‐PDL agent is included in the compound, the claim will reject for “invalid compound.” The pharmacy may place an “8” in the submission clarification code field and resubmit the claim; however, be advised that any component of a compound requiring prior authorization will necessitate an approval prior to receiving payment from the Nevada Medicaid Pharmacy Program. Provider Instruction · There are three segments that must be completed to submit a compound claim. Nevada Medicaid is listing the required entries by NCPDP field numbers. If you are unsure where these specific fields are located in your software please contact your software provider and give them the full Payer Specification Sheet for the Nevada Medicaid Pharmacy program that is included in this manual under Appendix B. P · On Claim Segment: o o o o Enter PRODUCT CODE/NDC (NCPDP field # 407‐D7) as “00000000000” on the claim segment to identify the claim as a multi‐ingredient compound. Enter COMPOUND CODE (NCPDP field # 406‐D6) of “2.” Enter QUANTITY DISPENSED (NCPDP field # 442‐E7) for the entire product. Enter INGREDIENT DRUG COST (NCPDP field # 409‐D9) of the entire product. § Updated 05/15/2012 This must equal the sum of the individual ingredient drug costs submitted in the compound segment. Page 19 of 27 o o o Enter GROSS AMOUNT DUE (NCPDP field # 430‐DU) for the entire product. Enter USUAL AND CUSTOMARY CHARGE (NCPDP field # 426‐DQ) for entire product. SUBMISSION CLARIFICATION CODE (NCPDP field # 420‐DK) = 8 (Process Compound for Approved Ingredients) allows a claim to continue processing if at least one ingredient is covered. This is only needed if the compound contains a non‐covered ingredient (see section 3.14 above). · On Compound Segment: o COMPOUND DISPENSING UNIT FORM INDICATOR (NCPDP field # 451‐EG) Acceptable values are ML or GM o COMPOUND ROUTE OF ADMINISTRATION (NCPDP field # 452‐EH) Example values are 1) 2) 3) 4) 5) 6) o o 3 = Inhalation 4 = Injection 11 = Oral 13 = Otic 15 = Rectal 17 = Topical COMPOUND INGREDIENT COMPONENT COUNT (NCPDP field # 447‐ EC) ‐ must equal the number of NDCs transmitted in the compound segment (Maximum of 25). For each line item (ingredient): COMPOUND PRODUCT ID QUALIFIER (NCPDP field # 488‐RE), always 03 = NDC COMPOUND PRODUCT ID (NCPDP field # 489‐TE), NDC of ingredient COMPOUND INGREDIENT QUANTITY (NCPDP field # 448‐ED), quantity of the individual ingredient included in the compound COMPOUND INGREDIENT DRUG COST (NCPDP field # 449‐EE), cost of the individual ingredient included in the compound Important Notes · · The Claim Segment Product ID (i.e., NDC) is defined as a mandatory field and, therefore, must be submitted for all claims, including multi‐ingredient compounds. A non‐blank space value is expected in the Claim Segment Product ID field for field validation. The pharmacy submits all zeroes in this field for a multi‐ingredient compound. For compound segment transactions, the claim is rejected if all zeroes are not submitted as the Product ID. A Submission Clarification Code value of “8” only allows a claim to continue processing if at least one ingredient is covered. Non‐rebateable ingredients will process with the submission clarification code, but only rebateable ingredients are eligible for reimbursement. Each multi‐ingredient compound claim counts as one claim toward the Brand Rx fill limits, if applicable. Pharmacies must transmit the same NDC numbers that are being used to dispense the medication. Compounds that contain an antibiotic must also contain another active ingredient. For example, an antibiotic suspension plus flavoring or an injectable antibiotic plus a fluid will not be covered as a compound. Coverage of Active Pharmaceutical Ingredients (APIs) Page 20 of 27 · · · · · Updated 05/15/2012 o An API is defined by 21 C.F.R. § 207.3(a)(4) as a bulk drug substance that “is represented for use in a drug and that, when used in the manufacturing, processing, or packaging of a drug, becomes an active ingredient or a finished dosage form of the drug.” APIs may be included in extemporaneously compounded prescriptions and may serve as the active drug component in a compounded formulation. 3.19 PARTIAL FILL FUNCTIONALITY Partial fill functionality allows pharmacies to bill for partial quantities of a single prescription. The following rules apply: · · · · · Partial fills must be billed via the POS system. The dispensing fee is prorated according to the quantity dispenses. Partial fill functionality cannot be used with multi‐ingredient compound claims. Partial fills may not be transferred from one pharmacy to another. You may not submit two partial fill transactions for the same prescription on the same day; the service date must be different for each partial fill. The following sections list the NCPDP fields that are required to submit initial, subsequent and final claims using the partial fill functionality. · Initial Claims – Complete these fields on an initial partial fill claim. • Quantity Dispensed (Field 442‐E7): Enter the actual quantity dispensed for this claim. • Days’ Supply (Field 405‐D5): Enter the number of days' supply that was dispensed for this claim. • Dispensing Status (Field 343‐HD): Enter “P” in this field. • Quantity Intended to be dispensed (Field 344‐HF): Enter the total quantity that was prescribed. • Days’ Supply Intended to be dispensed (Field 345‐HG): Enter the total days' supply that was prescribed. Subsequent Claims – Complete these fields on a subsequent partial fill claim. • Associated Prescription/Service Reference Number (Field 456‐EN): Enter the prescription number from the initial partial fill. • Associated Prescription/Service Date (Field 457‐EP): Enter the date of service of the most recent partial fill in the series. • Quantity Dispensed (Field 442‐E7): Enter the actual quantity dispensed for this claim. • Days’ Supply (Field 405‐D5): Enter the number of days' supply that was dispensed. • Dispensing Status (Field 343‐HD): Enter “P” in this field. • Quantity Intended to be Dispensed (Field 344‐HF): Enter the total quantity that was prescribed. • Days’ Supply Intended to be Dispensed (Field 345‐HG): Enter the total days' supply that was prescribed. Final Claim – Complete these fields on a final partial fill claim: • Associated Prescription/Service Reference Number (Field 456‐EN): Enter the prescription number from the initial partial fill. • Associated Prescription/Service Date (Field 457‐EP): Enter the date of service of the most recent partial fill in the series. • Quantity Dispensed (Field 442‐E7): Enter the actual quantity dispensed for this claim. • Days’ Supply (Field 405‐D5): Enter the number of days supply dispensed. • Dispensing Status (Field 343‐HD): Enter “C” in this field. Page 21 of 27 · · Updated 05/15/2012 • • Quantity Intended to be Dispensed (Field 344‐HF): Enter the total quantity that was prescribed. Days’ Supply Intended to be Dispensed (Field 345‐HG): Enter the total days' supply that was prescribed. 3.20 INJECTABLE DRUGS Intravenous (I.V.) therapy drugs claims must be submitted through the pharmacy POS system using the Multi‐Ingredient Functionality. · Dispensing Fees: • For outpatient antibiotic therapy, a daily dispensing fee of $22.40 will be applied to the claim. • For recipients in Long Term Care, a daily dispensing fee of $16.80 will be applied to the claim. This fee will be multiplied by the number of days the therapy was provided. Supplies • I.V. therapy supplies, enteral nutrition/supplies, Standard Total Parenteral Nutrition (TPN) solution and supplies are billed on CMS‐1500 claims form or through the 837P electronic transaction. Medications added to TPN Solution immediately prior to administration are billed through the pharmacy POS system. • For coverage and limitations, see the Billing Guidelines for Provider Type 33 (on the http://www.medicaid.nv.gov website), MSM Chapter 1200, Section 1203.2 and MSM Chapter 1300 (on the http://dhcfp.nv.gov website). · 3.21 REFILLS Dispense refills pursuant to the orders of the physician, but not more than one year from the date of the original prescription. Early refills may be dispensed only when 80% of the prescription is used for non‐controlled drugs and 90% for controlled drugs. Recipients must use drugs in accordance with the prescriber’s orders. 3.22 VACATION FILL To override an Early Refill denial message for a non‐controlled substance (Reject Code 88) where the prescriber has authorized a vacation fill, enter ‘03’ as the Submission Clarification Code (Field 420‐DK). 3.23 LOST MEDICATION The recipient is responsible for payment to replace lost, stolen or otherwise destroyed medication even if a physician writes a new prescription for the drug. Prior authorization may be granted in life‐threatening situation for maintenance medication (refer to MSM Chapter 1200). 4.0 PROSPECTIVE DRUG UTILIZATION REVIEW (PRODUR) Prospective Drug Utilization Review (ProDUR) encompasses the detection, evaluation, and counseling components of pre‐dispensing drug therapy screening. The ProDUR system assists the pharmacist in these functions by addressing situations in which potential Updated 05/15/2012 Page 22 of 27 drug problems may exist. ProDUR performed prior to dispensing helps pharmacists ensure that their recipients receive appropriate medications. This is accomplished by providing information to the dispensing pharmacist that may not have been previously available. Because SXC Health Solutions’ ProDUR system examines claims from all participating pharmacies, drugs that interact or are affected by previously dispensed medications can be detected. ProDUR edits can detect the following potential problems: therapeutic duplication, early refills, high dose, drug‐drug interactions, drug‐inferred diagnosis interactions, drug‐gender edits, and geriatric or pediatric precautions. SXC Health Solutions recognizes that the pharmacist uses his/her education and professional judgment in all aspects of dispensing. ProDUR is offered as an informational tool to aid the pharmacist in performing his/her professional duties. If a pharmacist assesses a potential drug therapy problem, and determines that the prescription should be dispensed, the pharmacist can override the ProDUR edit at point of sale using Pharmacy Professional Service (PPS) Codes (See table below). Exceptions include ProDUR edits involving: narcotic analgesics, sedative hypnotics, benzodiazepines, or skeletal muscle relaxants. ProDUR edits for these four classes require a call to the call center in order to obtain an override. Pharmacy Professional Service Codes Response Field Conflict Code DD HD TD DC LD MN MX PA Intervention Code M0 P0 R0 Outcome Code 1A 1B 1C 1D 1E 1G Response Codes Drug-Drug Interaction High Dose Therapeutic Duplication Drug-Disease Low Dose Insufficient Duration Excessive Duration Drug-Age Prescriber consulted Patient consulted Pharmacist consulted other source Filled As Is, False Positive Filled Prescription As IS Filled, With Different Dose Filled, With Different Directions Filled, With Different Quantity Filled, With Prescriber Approval Updated 05/15/2012 Page 23 of 27 4.1 THERAPEUTIC AND CLINICAL EDITS Therapeutic Duplication A Therapeutic Duplication edit has been enabled for specific therapeutic classes as a safety precaution. Claims encountering this edit are denied with a NCPDP “88” Reject ‐TD. Additional information is shared as outlined in Section 4.3 below. Therapeutic Duplication Alert Classes* ACE Inhibitors ACE Inhibitors/CCB Alpha Blockers Angiotensin Receptor Blockers Antiarthritics (NSAIDS, COX‐II) Antidepressants (SSRI, SNRI) Antidepressants (TCAs) Antihistamines Antipsychotics Benzodiazepines (Anxiety) Benzodiazepines (Insomnia) Beta Blockers Bile Salt Sequestrants Calcium Channel Blockers PPIs H2RAs Leukotrienes Statins (lipotropics) Fibrates (lipotropics) Narcotic Analgesics Quinolones Skeletal Muscle Relaxants *This list may not be all inclusive and is subject to change. 4.2 CALL CENTERS SXC Health Solutions’ Technical Call Center is available 24 hours per day, seven days a week. The telephone number is (866) 244‐ 8554. Alert message information is available from the Technical Call Center after the message appears. If you need assistance with any alert or denial messages, it is important to contact the Technical Call Center about ProDUR messages at the time of dispensing. The Technical Call Center can provide claims information on all error messages, which are sent by the ProDUR system. This information includes: NDCs and drug names of the affected drugs, dates of service, whether the calling pharmacy is the dispensing pharmacy of the conflicting drug, and days’ supply. The Technical Call Center is not intended to be used as a clinical consulting service and cannot replace or supplement the professional judgment of the dispensing pharmacist. SXC Health Solutions has used reasonable care to accurately compile ProDUR information. Because each clinical situation is unique, this information is intended for pharmacists to use at their own discretion in the drug therapy management of their recipients. A second level of assistance is available if a provider’s question requires a clinical response. To address these situations, SXC clinical pharmacists are available for consultation and are located at the Clinical Call Center. 4.3 PRODUR ALERT/ERROR MESSAGES ProDUR is an integral part of the Nevada Medicaid Pharmacy Program’s claims adjudication process. ProDUR includes: reviewing claims for therapeutic appropriateness before the medication is dispensed, reviewing the available medical history, focusing on those recipients at the highest severity of risk for harmful outcome, and intervening and/or counseling when appropriate. All ProDUR alert messages appear at the end of the claims adjudication transmission. Alerts appear in the following format: Updated 05/15/2012 Page 24 of 27 Format Reason for Service Severity Index Code Other Pharmacy Indicator Field Definitions Up to three characters. Code transmitted to pharmacy when a conflict is detected (e.g., ER, HR, TD, DD). One character. Code indicates how critical a given conflict is. One character. Indicates if the dispensing provider also dispensed the first drug in question. 1 = Your Pharmacy 3 = Other Pharmacy Eight characters. Indicates previous fill date of conflicting drug in YYYY/MM/DD format. Five characters. Indicates quantity of conflicting drug previously dispensed. One character. Indicates source of ProDUR message. 1 = First Data Bank 4 = Processor Developed One character. Indicates the prescriber of conflicting prescription. 0 = No Value 1 = Same Prescriber 2 = Other Prescriber Previous Date of Fill Quantity of Previous Fill Database Indicator Other Prescriber 5.0 PROVIDER REIMBURSEMENT 5.1 SWITCHING FEES SXC does NOT charge any switching fees for any claims. Pharmacies may be charged switching fees by their individual “claims switching service.” Pharmacies are encouraged to consult with their claims switching service for further details. 5.2 AMBULATORY/LTC NETWORK PHARMACY PAYMENT ALGORITHMS Pricing for all drugs and supplies (except diabetic, family planning supplies and immunizations) is always the “lesser of”: • • • • • • Wholesale Acquisition Cost (WAC) + 2% + Dispensing Fee Federal Upper Limit (FUL) + Dispensing Fee Maximum Allowable Cost (MAC) + Dispensing Fee Department of Justice (DOJ) – 15% + Dispensing Fee Gross Amount Due (Field 430‐DU) (Submitted) Usual and Customary (Field 425‐DQ) (Submitted) Updated 05/15/2012 Page 25 of 27 Pricing for Diabetic and Family Planning Supplies is always the “Lesser of”: • • • Wholesale Acquisition Cost (WAC) + 8% + $1.54 Dispensing Fee Gross Amount Due (Field 430‐DU) Usual and Customary (Field 425‐DQ) Compounds (Other than Home I.V. antibiotics) Each individual ingredient is priced as above + the applicable dispense fee. The lesser of calculated amount, Usual and Customary, and Gross Amount Due are reimbursed. There are no additional repackaging fees. 5.3 AMBULATORY/LTC NETWORK PHARMACY DISPENSING FEES Dispensing fee is currently $4.76 per claim. 5.4 PHARMACIST ‐ ADMINISTERED IMMUNIZATIONS Effective April 17, 2012, Nevada Medicaid and Nevada Check Up will reimburse pharmacies for administering adult and childhood immunizations. Requirements · · · · · · The administering pharmacist must be appropriately certified by the Nevada State Board of Pharmacy. Records must be kept on file for auditing. Pharmacies are responsible for physician oversight of the program and other state licensing requirements per Nevada Board of Pharmacy Rules. Pharmacies must enter immunization given in the Nevada WebIZ Website. Pharmacies must enroll in the Vaccines for Children Program (VFC). VFC vaccines are provided to pharmacies by the Nevada State Health Division for recipients who are under 19 years of age at no cost to the provider. The following is a list of covered immunizations: Covered Vaccine · Influenza · Tetanus, diphtheria, pertussis (Td/Tdap) · Varicella · HPV (Male and Female) (Provided through VFC program through age 18) · Zoster (only covered for recipients 50 years‐old and greater, not included in VFC) · Measles, Mumps, Rubella (MMR) · Pneumococcal · Meningococcal · Hepatitis A · Hepatitis B · Inactivated Poliovirus · Haemophilus influenza type b · Rotavirus Updated 05/15/2012 Page 26 of 27 Reimbursement · · · · The administration fee is $7.80 if administered in the pharmacy. If dispensed and administered off site, the pharmacy will be reimbursed the standard dispensing fee. All claims should be submitted through the Pharmacy Point of Sale System. Pharmacies will not be reimbursed an ingredient cost for VFC Program Immunization, but pharmacies will receive the administration fee. Ingredient cost will be reimbursed using the lesser‐of logic payment algorithm (refer to page 25). For non‐VFC immunizations that are dispensed but not administered, pharmacies will receive reimbursement for the ingredient cost and a dispensing fee. · Claims Submission for Pharmacist Administered Immunizations · For POS claims: o Submit ingredient cost submitted (409‐D9). o Submit Dispensing Fee Submitted (412‐DC). o Submit Patient Paid Amount (433‐DX). o It is not required, but Incentive Amount (433‐E3) may be submitted. o Submit Gross Amount Due (430‐DU). o All other fields are the same as standard POS claims. Response for POS claims: o You will only be reimbursed what is allowed according the payment algorithm. o If the recipient is 18 years‐old or less, a zero ingredient cost (506‐F6) will be returned, if the recipient is over 19 years‐old or over, the ingredient cost will be reimbursed based on the algorithm above. o The administration fee will be returned in the Incentive Fee field (521‐FL) for all claims for immunizations. · For more information: Visit: http://health.nv.gov/Immunization.htm or http://health.nv.gov/vaccine_VFCProgram.htm for information specific for Vaccine for Children (VFC). All vaccines administered must be documented in Nevada’s WebIZ – the Statewide Immunization Information System. Please visit: http://health.nv.gov/immunization_WebIZ‐Info.htm for enrollment information. 6.0 PROVIDER EDUCATION · · · · Provider Educators are available to assist Nevada Medicaid providers who may have questions regarding the pharmacy program (i.e., Preferred Drug List (PDL), Point‐of‐sale messaging, etc). In addition to ensuring PDL compliance, the overall objective for provider educators is to improve provider awareness of the Nevada Medicaid pharmacy program policies and procedures. Regular training sessions are held via teleconference throughout the year. Please refer to https://www.medicaid.nv.gov for dates and times. Select “Announcements/Training” from the “Pharmacy” tab. Email [email protected] or call (775) 335‐8537 to request training or ask questions. Updated 05/15/2012 Page 27 of 27
Microsoft Word - NV Medicaid and NV Check Up Pharmacy Manual V2 2012 05-15.docx
NEVADA CHECK UP: Authorized under Title XXI of the Social Security Act, Nevada Check Up (NCU) is the State of Nevada’s Children’s Health Insurance Program.